LLY

937.68

+0.48%↑

JNJ

186.61

+0.02%↑

UNH

322.79

-1.3%↓

NVS

126.66

+0.84%↑

ABT

124.56

-0.22%↓

LLY

937.68

+0.48%↑

JNJ

186.61

+0.02%↑

UNH

322.79

-1.3%↓

NVS

126.66

+0.84%↑

ABT

124.56

-0.22%↓

LLY

937.68

+0.48%↑

JNJ

186.61

+0.02%↑

UNH

322.79

-1.3%↓

NVS

126.66

+0.84%↑

ABT

124.56

-0.22%↓

LLY

937.68

+0.48%↑

JNJ

186.61

+0.02%↑

UNH

322.79

-1.3%↓

NVS

126.66

+0.84%↑

ABT

124.56

-0.22%↓

LLY

937.68

+0.48%↑

JNJ

186.61

+0.02%↑

UNH

322.79

-1.3%↓

NVS

126.66

+0.84%↑

ABT

124.56

-0.22%↓

McKesson Corp

Отворен

СекторЗдравеопазване

858.05 0.89

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

787

Максимум

858.41

Ключови измерители

By Trading Economics

Приходи

-522M

784M

Продажби

7B

98B

P/E

Средно за сектора

32.891

77.256

Дивидентна доходност

0.35

Марж на печалбата

0.801

Служители

43,000

EBITDA

-454M

1.3B

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+0.95% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.35%

2.33%

Следваща дата на дивидент

2.01.2026 г.

Следваща дата на екс-дивидент

1.12.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

13B

102B

Предишно отваряне

857.16

Предишно затваряне

858.05

Настроения в новините

By Acuity

46%

54%

159 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.11.2025 г., 23:51 ч. UTC

Печалби

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5.11.2025 г., 23:10 ч. UTC

Печалби

DBS Third Quarter Net Dips 2.0%

5.11.2025 г., 22:55 ч. UTC

Печалби

Arm Holdings 2Q Profit Climbs on Record Demand

5.11.2025 г., 22:23 ч. UTC

Печалби

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5.11.2025 г., 23:52 ч. UTC

Печалби

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5.11.2025 г., 23:49 ч. UTC

Печалби

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5.11.2025 г., 23:49 ч. UTC

Печалби

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5.11.2025 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5.11.2025 г., 23:42 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5.11.2025 г., 23:12 ч. UTC

Печалби

Nutrien 3Q Adj EPS 97c >NTR.T

5.11.2025 г., 23:11 ч. UTC

Печалби

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5.11.2025 г., 23:10 ч. UTC

Печалби

Nutrien 3Q Sales $6.01B >NTR.T

5.11.2025 г., 23:10 ч. UTC

Пазарно говорене
Печалби

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5.11.2025 г., 23:10 ч. UTC

Печалби

Nutrien 3Q EPS 96c >NTR.T

5.11.2025 г., 23:04 ч. UTC

Печалби

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5.11.2025 г., 23:03 ч. UTC

Пазарно говорене

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5.11.2025 г., 22:55 ч. UTC

Пазарно говорене

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5.11.2025 г., 22:55 ч. UTC

Печалби

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5.11.2025 г., 22:51 ч. UTC

Печалби

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5.11.2025 г., 22:50 ч. UTC

Печалби

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5.11.2025 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5.11.2025 г., 22:43 ч. UTC

Пазарно говорене
Печалби

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5.11.2025 г., 22:36 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

5.11.2025 г., 22:36 ч. UTC

Пазарно говорене

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5.11.2025 г., 22:20 ч. UTC

Пазарно говорене

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5.11.2025 г., 22:12 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5.11.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5.11.2025 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Responds to Delaware Chancery Court Ruling

5.11.2025 г., 22:01 ч. UTC

Печалби

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5.11.2025 г., 22:01 ч. UTC

Печалби

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

0.95% нагоре

12-месечна прогноза

Среден 849.67 USD  0.95%

Висок 920 USD

Нисък 770 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

12

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

No Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

159 / 374 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat